Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction. uri icon

authors

  • England, Elizabeth
  • Majithiya, Jayesh B
  • Rapley, Laura
  • Sims, Dorothy A
  • Hollins, Claire
  • Hinchy, Elizabeth C
  • Strain, Martin D
  • Kemp, Benjamin P
  • Corkill, Dominic J
  • May, Richard D
  • Vousden, Katherine A
  • Rees, D Gareth
  • Butler, Robin J
  • Mustelin, Tomas
  • Vaughan, Tristan J
  • Lowe, David C
  • Colley, Caroline
  • Cohen, E Suzanne
  • Scott, Ian Christopher
  • Carmen, Sara
  • Chan, Denice T Y
  • Chaillan Huntington, Catherine E
  • Houslay, Kirsty F
  • Erngren, Teodor
  • Penney, Mark

publication date

  • January 1, 2023